Clinical Trial Update: A Compassionate Use Study of Leronlimab in Breast Cancer

View source ↗

Summary

This document reports that a compassionate-use study of leronlimab for metastatic triple-negative breast cancer is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Leronlimab (leronlimab)

Snippet

Sponsor: CytoDyn, Inc. | Conditions: Metastatic Triple-Negative Breast Carcinoma | Status: NO_LONGER_AVAILABLE